Challenging antibiotic resistance with dual-action macrolones

FHS
July 24, 2024
11:50 am

A new antibiotic that works by disrupting two different cellular targets would make it 100 million times more difficult for bacteria to evolve resistance, according to new research from the University of Illinois Chicago.

Novavax seeks EMA approval for updated JN.1 Covid-19 vaccine

NVX-CoV2705 is a modified formulation of the original Covid-19 vaccine. Credit: benjamin poturak / Shutterstock. Novavax has submitted a type II variation application with the

June 25, 2024

Can drones delivering defibrillators outpace ambulances in saving lives during cardiac arrests?

Automated external defibrillators (AEDs) are commonly used to restore the heartbeat in cardiac arrest patients.

December 4, 2023

Researchers identify protein linked to cardiovascular health in progeria

A new University of Maryland-led discovery could spur the development of new and improved treatments for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder with

October 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.